Skip to main content Accessibility help
×
Home

Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: Severe negative syndrome may be related to a distinct lipid pathophysiology

  • S.-F. Chen (a1) (a2), T.-M. Hu (a3), T.-H. Lan (a2) (a4) (a5), H.-J. Chiu (a4) (a6) (a7), L.-Y. Sheen (a1) and E.-W. Loh (a2) (a8)...

Abstract

Background:

Metabolic abnormality is common among schizophrenia patients. Some metabolic traits were found associated with subgroups of schizophrenia patients.

Objectives:

We examined a possible relationship between metabolic abnormality and psychosis profile in schizophrenia patients.

Method:

Three hundred and seventy-two chronic schizophrenia patients treated with antipsychotics for more than 2 years were assessed with the Positive and Negative Syndrome Scale. A set of metabolic traits was measured at scheduled checkpoints between October 2004 and September 2006.

Results:

Multiple regressions adjusted for sex showed negative correlations between body mass index (BMI) and total score and all subscales; triglycerides (TG) was negatively correlated with total score and negative syndrome, while HDLC was positively correlated with negative syndrome. When sex interaction was concerned, total score was negatively correlated with BMI but not with others; negative syndrome was negatively correlated with BMI and positively with HDLC. No metabolic traits were correlated with positive syndrome or general psychopathology.

Conclusions:

Loss of body weight is a serious health problem in schizophrenia patients with severe psychosis syndrome, especially the negative syndrome. Schizophrenia patients with severe negative syndrome may have a distinct lipid pathophysiology in comparison with those who were less severe in the domain.

Copyright

Corresponding author

*Corresponding author. Institute of Food Science and Technology, National Taiwan University, Roosevelt Road Section 4, Taipei, Taiwan. Tel.: +886 2 3366 4129; fax: +886 2 2362 0849. E-mail addresses:lysheen@ntu.edu.tw (L.-Y. Sheen)
**Corresponding author. Kaohsiung Municipal Kai-Syuan Psychiatric Hospital, No.130, Kaisyuan 2nd Rd., Lingya Dist., Kaohsiung City 80276, Taiwan (R.O.C.). Tel: +886 7 751 3171; fax: +886 7 771 2494. E-mail addresses:lohelwui@yahoo.com.tw (E.-W. Loh).

References

Hide All
[1]Andreasen, NCNegative syndrome in schizophrenia: strategies for long-term management. Adv Biochem Psychopharmacol 1985;40:17.
[2]Bai, YM, Lin, CC, Chen, JY, Lin, CY, Su, TP, Chou, PAssociation of initial antipsychotic response to clozapine and long-term weight gain. Am J Psychiatry 2006;163:12761279.
[3]Bellino, S, Rocca, P, Patria, L, Marchiaro, L, Rasetti, R, Di Lorenzo, Ret al.Relationships of age at onset with clinical features and cognitive functions in a sample of schizophrenia patients. J Clin Psychiatry 2004;65:908914.
[4]Carpenter, WTJRClinical constructs and therapeutic discovery. Schizophr Res 2004;72:6973.
[5]Cheng, JJ, Ho, H, Chang, CJ, Lane, HY, Hu, HGPositive and negative syndrome scale (PANSS): establishment and reliability study of a mandarin Chinese language version. Chin Psychiatry 1996;10:251258.
[6]Chien, IC, Hsu, JH, Lin, CH, Bih, SH, Chou, YJ, Chou, PPrevalence of diabetes in patients with schizophrenia in Taiwan: a population-based National Health Insurance study. Schizophr Res 2009;111:1722.
[7]Chiu, HJ, Loh, EW, Lan, TH, Sou, JH, Hsieh, HC, Hu, TMIncrease of incidence of impaired fasting glucose in young schizophrenia patients. Psychiatry Clin Neurosci 2009;63:127128.
[8]Crow, TJMolecular pathology of schizophrenia: more than one disease process? Br Med J 1980;280:6668.
[9]Crow, TJPositive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 1980;137:383386.
[10]Davidson, M, Harvey, PD, Powchik, P, Parrella, M, White, L, Knobler, HYet al.Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 1995;152:197207.
[11]Fraguas, D, de Castro, MJ, Medina, O, Parellada, M, Moreno, D, Graell, Met al.Does diagnostic classification of early-onset psychosis change over follow-up?. Child Psychiatry Hum Dev 2008;39:137145.
[12]Freeman, LR, Haley-Zitlin, V, Stevens, C, Granholm, ACDiet-induced effects on neuronal and glial elements in the middle-aged rat hippocampus. Nutr Neurosci 2011;14:3244.
[13]Hayashi, HLipid metabolism and glial lipoproteins in the central nervous system. Biol Pharm Bull 2011;34:453461.
[14]Horrobin, DFThe membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophr Res 1998;30:193208.
[15]Horrobin, DF, Manku, MS, Hillman, H, Iain, A, Glen, MFatty acid levels in the brains of schizophrenics and normal controls. Biol Psychiatry 1991;30:795805.
[16]Huang, MC, Lu, ML, Tsai, CJ, Chen, PY, Chiu, CC, Jian, DLet al.Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan. Acta Psychiatr Scand 2009;120:274280.
[17]Hung, CF, Wu, CK, Lin, PYDiabetes mellitus in patients with schizophrenia in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:523527.
[18]Kao, YC, Liu, YPEffects of age of onset on clinical characteristics in schizophrenia spectrum disorders. BMC Psychiatry 2010;10:63.
[19]Kay, SR, Opler, LAThe positive-negative dimension in schizophrenia: its validity and significance. Psychiatr Dev 1987;5:79103.
[20]Meltzer, HY, Perry, E, Jayathilake, KClozapine-induced weight gain predicts improvement in psychopathology. Schizoph Res 2003;59:1927.
[21]Meltzer, HY, Bobo, WV, Lee, MA, Cola, P, Jayathilake, KA randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry Res 2010;177:286293.
[22]Procyshyn, RM, Wasan, KM, Thornton, AE, Barr, AM, Chen, EY, Pomarol-Clotet, Eet al.Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci 2007;32:331338.
[23]Richardson, AJ, Allen, SJ, Hajnal, JV, Cox, IJ, Easton, T, Puri, BKAssociations between central and peripheral measures of phospholipid breakdown revealed by cerebral 31-phosphorus magnetic resonance spectroscopy and fatty acid composition of erythrocyte membranes. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:15131521.
[24]Saari, K, Jokelainen, J, Veijola, J, Koponen, H, Jones, PB, Savolainen, Met al.Serum lipids in schizophrenia and other functional psychoses: a general population northern Finland 1966 birth cohort survey. Acta Psychiatr Scand 2004;110:279285.
[25]Saari, K, Lindeman, S, Koponen, H, Jokelainen, J, Isohanni, MHigher serum triglyceride levels in early-onset schizophrenia. Am J Psychiatry 2004;161:176.
[26]Sethom, MM, Fares, S, Bouaziz, N, Melki, W, Jemaa, R, Feki, Met al.Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia. Prostaglandins Leukot Essent Fatty Acids 2010;83:131136.
[27]Stranahan, AM, Cutler, RG, Button, C, Telljohann, R, Mattson, MPDiet-induced elevations in serum cholesterol are associated with alterations in hippocampal lipid metabolism and increased oxidative stress. J Neurochem 2011;118:611615.
[28]Wainwright, PEDietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc Nutr Soc 2002;61:6169.
[29]Williams, PT, Stefanick, ML, Vranizan, KM, Wood, PDThe effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med 1991;325:461466.
[30]Williams, PT, Stefanick, ML, Vranizan, KM, Wood, PDThe effects of weight loss by exercise or by dieting on plasma high-density lipoprotein (HDL) levels in men with low, intermediate, and normal-to-high HDL at baseline. Metabolism 1994;43:917924.
[31]Wood, PD, Stefanick, ML, Dreon, DM, Frey-Hewitt, B, Garay, SC, Williams, PTet al.Changes in plasma lipids and lipoproteins in overweight men during weight loss through dieting as compared with exercise. N Engl J Med 1998;319:11731179.
[32]Yang, YW, Fu, CYTwo advanced methods for adjusting the main coefficient in logistic regression. Comput Stat 2013;28:199218.
[33]Yao, JK, Leonard, S, Reddy, RDMembrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res 2000;42:717.
[34]Yao, J, Stanley, JA, Reddy, RD, Keshavan, MS, Pettegrew, JWCorrelations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites. Biol Psychiatry 2002;52:823830.

Keywords

Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: Severe negative syndrome may be related to a distinct lipid pathophysiology

  • S.-F. Chen (a1) (a2), T.-M. Hu (a3), T.-H. Lan (a2) (a4) (a5), H.-J. Chiu (a4) (a6) (a7), L.-Y. Sheen (a1) and E.-W. Loh (a2) (a8)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: Severe negative syndrome may be related to a distinct lipid pathophysiology

  • S.-F. Chen (a1) (a2), T.-M. Hu (a3), T.-H. Lan (a2) (a4) (a5), H.-J. Chiu (a4) (a6) (a7), L.-Y. Sheen (a1) and E.-W. Loh (a2) (a8)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *